Equities

QuidelOrtho Corp

QuidelOrtho Corp

Actions
Health CareMedical Equipment and Services
  • Price (USD)43.75
  • Today's Change4.90 / 12.61%
  • Shares traded2.49m
  • 1 Year change-27.43%
  • Beta0.1219
Data delayed at least 15 minutes, as of Nov 08 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments167345829
Total Receivables, Net442542394
Total Inventory578524199
Prepaid expenses6714115
Other current assets, total56234.59
Total current assets1,3111,5751,440
Property, plant & equipment, net1,6131,520477
Goodwill, net2,4922,477337
Intangibles, net2,9343,12499
Long term investments7.402138
Note receivable - long term------
Other long term assets18012320
Total assets8,5638,8562,430
LIABILITIES
Accounts payable295283101
Accrued expenses20616461
Notes payable/short-term debt000
Current portion long-term debt/capital leases140208--
Other current liabilities, total194353161
Total current liabilities8341,007324
Total long term debt2,2752,4310
Total debt2,4152,6380
Deferred income tax192213--
Minority interest------
Other liabilities, total256270177
Total liabilities3,5573,921501
SHAREHOLDERS EQUITY
Common stock0.100.070.04
Additional paid-in capital2,8482,804280
Retained earnings (accumulated deficit)2,1882,1981,649
Treasury stock - common------
Unrealized gain (loss)(19)(70)--
Other equity, total(11)2.130.36
Total equity5,0064,9351,929
Total liabilities & shareholders' equity8,5638,8562,430
Total common shares outstanding676642
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.